District of Columbia Statutes

§ 28-4554 — Burden of proof; determination of excessive pricing.

District of Columbia·Title 28 Commercial Instruments and Transactions. [Enacted title]·Ch. 45B Excessive Pricing.
(a)A prima facie case of excessive pricing shall be established where the wholesale price of a patented prescription drug in the District is over 30% higher than the comparable price in any high income country in which the product is protected by patents or other exclusive marketing rights.
(b)Where a prima facie case of excessive pricing is shown, the burdens of providing evidence and of proving by a preponderance of the evidence shall shift to the defendant to show that a given prescription drug is not excessively priced given demonstrated costs of invention, development and production of the prescription drug, global sales and profits to date, consideration of any government funded research that supported the development of the drug, and the impact of price on access to the prescript

Free access — add to your briefcase to read the full text and ask questions with AI

District of Columbia § 28-4554 (Burden of proof; determination of excessive pricing.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

Dec. 10, 2005, D.C. Law 16-37, § 2, 52 DCR 9061

Nearby Sections

15
View on official source ↗